165 related articles for article (PubMed ID: 32883636)
1. Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
Ahmad H; Ullah S; Rahman F; Saeed A; Pelletier J; Sévigny J; Hassan A; Iqbal J
Eur J Med Chem; 2020 Dec; 208():112759. PubMed ID: 32883636
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
El-Gamal MI; Ullah S; Zaraei SO; Jalil S; Zaib S; Zaher DM; Omar HA; Anbar HS; Pelletier J; Sévigny J; Iqbal J
Eur J Med Chem; 2019 Nov; 181():111560. PubMed ID: 31382118
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors.
Semreen MH; El-Gamal MI; Ullah S; Jalil S; Zaib S; Anbar HS; Lecka J; Sévigny J; Iqbal J
Bioorg Med Chem; 2019 Jul; 27(13):2741-2752. PubMed ID: 31088715
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
Tasleem M; Pelletier J; Sévigny J; Hussain Z; Khan A; Al-Harrasi A; El-Kott AF; Taslimi P; Negm S; Shafiq Z; Iqbal J
Int J Biol Macromol; 2024 May; 266(Pt 2):131068. PubMed ID: 38531526
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
7. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.
Nassir M; Pelletier J; Arad U; Arguin G; Khazanov N; Gendron FP; Sévigny J; Senderowitz H; Fischer B
Eur J Med Chem; 2019 Dec; 184():111754. PubMed ID: 31610377
[TBL] [Abstract][Full Text] [Related]
9. Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
Lecka J; Ben-David G; Simhaev L; Eliahu S; Oscar J; Luyindula P; Pelletier J; Fischer B; Senderowitz H; Sévigny J
J Med Chem; 2013 Nov; 56(21):8308-20. PubMed ID: 24083941
[TBL] [Abstract][Full Text] [Related]
10. Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
Zelikman V; Pelletier J; Simhaev L; Sela A; Gendron FP; Arguin G; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2018 May; 61(9):3939-3951. PubMed ID: 29681152
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of ecto-nucleotide pyrophosphatase/phosphodiesterase I-1 (E-NPP1/PC-1) and -3 (E-NPP3/CD203c/PD-Ibeta/B10/gp130(RB13-6)) in inflammatory and neoplastic bile duct diseases.
Yano Y; Hayashi Y; Sano K; Nagano H; Nakaji M; Seo Y; Ninomiya T; Yoon S; Yokozaki H; Kasuga M
Cancer Lett; 2004 Apr; 207(2):139-47. PubMed ID: 15072822
[TBL] [Abstract][Full Text] [Related]
12. Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases.
Andleeb H; Hameed S; Ejaz SA; Khan I; Zaib S; Lecka J; Sévigny J; Iqbal J
Bioorg Chem; 2019 Jul; 88():102893. PubMed ID: 30986550
[TBL] [Abstract][Full Text] [Related]
13. Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors.
Lee SY; Perotti A; De Jonghe S; Herdewijn P; Hanck T; Müller CE
Bioorg Med Chem; 2016 Jul; 24(14):3157-65. PubMed ID: 27265686
[TBL] [Abstract][Full Text] [Related]
14. Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes.
Nassir M; Arad U; Lee SY; Journo S; Mirza S; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
Purinergic Signal; 2019 Jun; 15(2):247-263. PubMed ID: 31025169
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases.
Vollmayer P; Clair T; Goding JW; Sano K; Servos J; Zimmermann H
Eur J Biochem; 2003 Jul; 270(14):2971-8. PubMed ID: 12846830
[TBL] [Abstract][Full Text] [Related]
16. Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1.
Vaingankar SM; Fitzpatrick TA; Johnson K; Goding JW; Maurice M; Terkeltaub R
Am J Physiol Cell Physiol; 2004 May; 286(5):C1177-87. PubMed ID: 15075217
[TBL] [Abstract][Full Text] [Related]
17. Ectonucleotide pyrophosphatase/phosphodiesterase activity in Neuro-2a neuroblastoma cells: changes in expression associated with neuronal differentiation.
Gómez-Villafuertes R; Pintor J; Miras-Portugal MT; Gualix J
J Neurochem; 2014 Nov; 131(3):290-302. PubMed ID: 24947519
[TBL] [Abstract][Full Text] [Related]
18. Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.
Channar PA; Afzal S; Ejaz SA; Saeed A; Larik FA; Mahesar PA; Lecka J; Sévigny J; Erben MF; Iqbal J
Eur J Med Chem; 2018 Aug; 156():461-478. PubMed ID: 30015078
[TBL] [Abstract][Full Text] [Related]
19. Substrate-specifying determinants of the nucleotide pyrophosphatases/phosphodiesterases NPP1 and NPP2.
Cimpean A; Stefan C; Gijsbers R; Stalmans W; Bollen M
Biochem J; 2004 Jul; 381(Pt 1):71-7. PubMed ID: 15096095
[TBL] [Abstract][Full Text] [Related]
20. Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).
Chang L; Lee SY; Leonczak P; Rozenski J; De Jonghe S; Hanck T; Müller CE; Herdewijn P
J Med Chem; 2014 Dec; 57(23):10080-100. PubMed ID: 25372276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
